|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/15/24 Cryo Cell International Inc. 10-Q 2/29/24 66:9.2M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 939K
2: EX-10.5 Material Contract HTML 101K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 26K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 26K
5: EX-31.3 Certification -- §302 - SOA'02 HTML 26K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
8: R1 Cover Page HTML 73K
9: R2 Consolidated Balance Sheets HTML 159K
10: R3 Consolidated Balance Sheets (Parenthetical) HTML 45K
11: R4 Consolidated Statements of Income HTML 101K
12: R5 Consolidated Statements of Cash Flows HTML 117K
13: R6 Consolidated Statements of Stockholders' Deficit HTML 48K
14: R7 Description of Business, Basis of Presentation and HTML 222K
Significant Accounting Policies
15: R8 Segment Reporting HTML 102K
16: R9 Inventory HTML 44K
17: R10 Intangible Assets HTML 66K
18: R11 Notes Payable HTML 71K
19: R12 Income per Common Share HTML 48K
20: R13 Stockholders' Equity HTML 175K
21: R14 License Agreements HTML 24K
22: R15 Commitments and Contingencies HTML 28K
23: R16 Share Repurchase Plan HTML 29K
24: R17 Leases HTML 65K
25: R18 License Agreement with Duke HTML 60K
26: R19 Description of Business, Basis of Presentation and HTML 251K
Significant Accounting Policies (Policies)
27: R20 Description of Business, Basis of Presentation and HTML 147K
Significant Accounting Policies (Tables)
28: R21 Segment Reporting (Tables) HTML 96K
29: R22 Inventory (Tables) HTML 43K
30: R23 Intangible Assets (Tables) HTML 65K
31: R24 Notes Payable (Tables) HTML 54K
32: R25 Income per Common Share (Tables) HTML 46K
33: R26 Stockholders' Equity (Tables) HTML 151K
34: R27 Leases (Tables) HTML 70K
35: R28 Description of Business, Basis of Presentation and HTML 88K
Significant Accounting Policies - Additional
Information (Detail)
36: R29 Description of Business, Basis of Presentation and HTML 26K
Significant Accounting Policies - Additional
Information 1 (Detail)
37: R30 Description of Business, Basis of Presentation and HTML 31K
Significant Accounting Policies - Schedule of
Assets and Liabilities From Contracts With
Customers (Detail)
38: R31 Description of Business, Basis of Presentation and HTML 40K
Significant Accounting Policies - Schedule of
Change in Assets and Liabilities From Contracts
With Customers (Detail)
39: R32 Description of Business, Basis of Presentation and HTML 53K
Significant Accounting Policies - Financial Assets
and Liabilities Measured at Fair Value on
Recurring Basis (Detail)
40: R33 Segment Reporting - Additional Information HTML 22K
(Detail)
41: R34 Segment Reporting - Summary of Net Revenue, Cost HTML 63K
of Sales, Depreciation and Amortization, Operating
Profit, and Interest Expense and Assets by Segment
(Detail)
42: R35 Inventory - Components of Inventory (Detail) HTML 34K
43: R36 Intangible Assets - Schedule of Intangible Assets HTML 49K
(Detail)
44: R37 Intangible Assets - Additional Information HTML 23K
(Detail)
45: R38 Notes Payable - Additional Information (Detail) HTML 95K
46: R39 Notes Payable - Schedule of Note Payable HTML 35K
Obligation (Detail)
47: R40 Notes Payable - Summary of Interest Expense on HTML 29K
Note Payable (Detail)
48: R41 Income per Common Share - Calculation of Basic and HTML 55K
Diluted Net Income per Common Share (Detail)
49: R42 Income per Common Share - Additional Information HTML 25K
(Detail)
50: R43 Stockholders' Equity - Additional Information HTML 128K
(Detail)
51: R44 Stockholders' Equity - Fair Value of Options HTML 31K
Granted (Detail)
52: R45 Stockholders' Equity - Stock Option Activity HTML 72K
(Detail)
53: R46 Stockholders' Equity - Significant Option Groups HTML 82K
Outstanding and Exercisable Option and its Price
and Contractual Life (Detail)
54: R47 Stockholders' Equity - Summary of Non-Vested HTML 37K
Options (Detail)
55: R48 Commitments and Contingencies - Additional HTML 25K
Information (Detail)
56: R49 Share Repurchase Plan - Additional Information HTML 40K
(Detail)
57: R50 Leases - Summary of Lease Assets and Liabilities HTML 30K
(Detail)
58: R51 Leases - Summary of Maturity of the Company's HTML 33K
Lease Liabilities (Detail)
59: R52 Leases - Summary of Remaining Lease Term and HTML 25K
Discount Rates (Detail)
60: R53 Leases - Summary of Supplemental Cash Flow HTML 23K
Information Related to Leases (Detail)
61: R54 License Agreement with Duke - Additional HTML 139K
Information (Detail)
63: XML IDEA XML File -- Filing Summary XML 123K
66: XML XBRL Instance -- ccel-20240229_htm XML 2.30M
62: EXCEL IDEA Workbook of Financial Report Info XLSX 107K
7: EX-101.SCH XBRL Taxonomy Extension Schema With Embedded XSD 3.61M
Linkbases Document -- ccel-20240229
64: JSON XBRL Instance as JSON Data -- MetaLinks 492± 714K
65: ZIP XBRL Zipped Folder -- 0000950170-24-044493-xbrl Zip 270K
 | Download this zipped .zip folder |
| Files: | ccel-20240229.htm ccel-20240229.xsd ccel-ex10_5.htm ccel-ex31_1.htm ccel-ex31_2.htm ccel-ex31_3.htm ccel-ex32_1.htm |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 7/11/22 Cryo Cell International Inc. 10-Q 5/31/22 70:11M Donnelley … Solutions/FA 3/16/22 Cryo Cell International Inc. 8-K:1,8,9 3/14/22 12:1.2M Donnelley … Solutions/FA 2/22/22 Cryo Cell International Inc. 10-K 11/30/21 96:14M Donnelley … Solutions/FA 4/14/21 Cryo Cell International Inc. 10-Q 2/28/21 72:8.8M ActiveDisclosure/FA 12/11/18 Cryo Cell International Inc. 8-K:5,9 12/06/18 2:106K Donnelley … Solutions/FA 7/19/02 Cryo Cell International Inc. 10QSB 5/31/02 3:84K Donnelley … Solutions/FA |